Antiangiogenic therapy in human gastrointestinal malignancies

被引：8

作者：

Heidemann, J.

Binion, D. G.

Domschke, W.

Kucharzik, T.

机构：

[1] Univ Munster, Dept Med B, D-48129 Munster, Germany

[2] Med Coll Wisconsin, Dept Internal Med, Div Gastroenterol Hepatol, Milwaukee, WI 53226 USA

来源：

GUT | 2006年 / 55卷 / 10期

关键词：

D O I：

10.1136/gut.2005.088229

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Angiogenesis is a crucial process involved in numerous physiological and pathophysiological settings. During the past three decades, the field of tumour associated angiogenesis has been the focus of a plethora of basic research projects and clinical studies. Tumour associated neovessels satisfying the increased demand of oxygen and nutrients in malignant tumours are now emerging as specific targets for novel antineoplastic agents. This article discusses the present data on antiangiogenic treatment of human gastrointestinal malignancies, including gastric, pancreatic, and colorectal adenocarcinoma, and outlines potential future perspectives, such as development of surrogate markers of angiogenesis.

引用

收藏

页码：1497 / 1511

页数：15

相关论文

共 229 条

[61] Angiogenesis of gastrointestinal tumours and their metastases - a target for intervention? [J].

Garcea, G ;

Lloyd, TD ;

Gescher, A ;

Dennison, AR ;

Steward, WP ;

Berry, DP .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (09) :1302-1313

[62] Plasma basic fibroblast growth factor levels in colorectal cancer: A clinically useful assay? [J].

George, ML ;

Tutton, MG ;

Abulafi, AM ;

Eccles, SA ;

Swift, RI .

CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (08) :735-738

[63]

Giatromanolaki A, 1999, CANCER-AM CANCER SOC, V86, P1421, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1421::AID-CNCR6>3.0.CO

[64]

2-X

[65] Effect of thalidomide on gastrointestinal toxic effects of irinotecan [J].

Govindarajan, R ;

Heaton, KM ;

Broadwater, R ;

Zeitlin, A ;

Lang, NP ;

Hauer-Jensen, M .

LANCET, 2000, 356 (9229) :566-567

[66] Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer [J].

Harada Y. ;

Ogata Y. ;

Shirouzu K. .

International Journal of Clinical Oncology, 2001, 6 (5) :221-228

[67]

Haraguchi M, 2002, ONCOL REP, V9, P159

[68]

Hasegawa S, 2005, ONCOL REP, V13, P621

[69] Antiangiogenic treatment of mesenteric desmoid tumors with toremifene and interferon alfa-2b: Report of two cases [J].

Heidemann, J ;

Ogawa, H ;

Otterson, MF ;

Shidham, VB ;

Binion, DG .

DISEASES OF THE COLON & RECTUM, 2004, 47 (01) :118-122

[70] Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2 [J].

Heidemann, J ;

Ogawa, H ;

Dwinell, MB ;

Rafiee, P ;

Maaser, C ;

Gockel, HR ;

Otterson, MF ;

Ota, DM ;

Lügering, N ;

Domschke, W ;

Binion, DG .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (10) :8508-8515

← 2 3 4 5 6 7 8 9 10 11 →